Interviews with Medtech Startup CEOs

May Health CEO Colby Holtshouse is tackling PCOS and infertility with a minimally invasive ovarian ablation device. She explains why staged evidence — built in layers rather than a massive trial — is the fastest path to early commercial traction.

Reia CEO Kaitlin Maier turned a student project into the first self-managed pessary that treats all stages of pelvic organ prolapse — proving that limited resources can sharpen design, focus, and innovation.

Hera Biotech CEO Somer Baburek is developing AI-based tissue diagnostics for conditions like endometriosis — showing how thoughtful global trial design and small-scale acquisitions can stretch resources and speed progress.

BRIJ Medical CEO Tim Gleeson shares how innovating in a “boring” market can lead to big wins. He explains how BRIJ’s wound-closure clip gained traction by focusing on clinical champions, patients, and modern marketing.

Cooler Heads CEO Kate Dilligan built a scalp cooling device that prevents hair loss during chemo. Her key learning: design your device to fit health system workflows first — that's how you win real adoption.

Wellysis CEO Young Juhn on developing S-Patch, a lightweight wearable for long-term ECG monitoring — and why patient voices, not specs, should guide medtech design.